Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) shows the opportunity to treat a diverse array of untreated various genetic and complicated disorders. Therapeutic genome editing processes that target disease-causing genes or mutant genes have been greatly...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasul, Mohammed Fatih, Hussen, Bashdar Mahmud, Salihi, Abbas, Ismael, Bnar Saleh, Jalal, Paywast Jamal, Zanichelli, Anna, Jamali, Elena, Baniahmad, Aria, Ghafouri-Fard, Soudeh, Basiri, Abbas, Taheri, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892709/
https://www.ncbi.nlm.nih.gov/pubmed/35241090
http://dx.doi.org/10.1186/s12943-021-01487-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892709/
https://www.ncbi.nlm.nih.gov/pubmed/35241090
http://dx.doi.org/10.1186/s12943-021-01487-4

Ejemplares similares